SG10202000552YA - Peptides and compositions for prevention of cell adhesion and methods of using same - Google Patents

Peptides and compositions for prevention of cell adhesion and methods of using same

Info

Publication number
SG10202000552YA
SG10202000552YA SG10202000552YA SG10202000552YA SG10202000552YA SG 10202000552Y A SG10202000552Y A SG 10202000552YA SG 10202000552Y A SG10202000552Y A SG 10202000552YA SG 10202000552Y A SG10202000552Y A SG 10202000552YA SG 10202000552Y A SG10202000552Y A SG 10202000552YA
Authority
SG
Singapore
Prior art keywords
peptides
prevention
compositions
methods
same
Prior art date
Application number
SG10202000552YA
Other languages
English (en)
Inventor
Amir Zlotkin
Hen Kestenboim
Original Assignee
Tel Hashomer Medical Research Infrastructure And Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tel Hashomer Medical Research Infrastructure And Services Ltd filed Critical Tel Hashomer Medical Research Infrastructure And Services Ltd
Publication of SG10202000552YA publication Critical patent/SG10202000552YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04—Macromolecular materials
    • A61L29/044—Proteins; Polypeptides; Degradation products thereof
    • A61L29/048—Other specific proteins or polypeptides not covered by A61L29/045 - A61L29/047
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
    • C09D5/16—Antifouling paints; Underwater paints
    • C09D5/1606—Antifouling paints; Underwater paints characterised by the anti-fouling agent
    • C09D5/1612—Non-macromolecular compounds
    • C09D5/1625—Non-macromolecular compounds organic
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00—Specific treatment goals
    • C02F2303/20—Prevention of biofouling
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00—Biological treatment of water, waste water, or sewage
    • C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10202000552YA 2008-09-24 2009-09-23 Peptides and compositions for prevention of cell adhesion and methods of using same SG10202000552YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13667308P 2008-09-24 2008-09-24

Publications (1)

Publication Number Publication Date
SG10202000552YA true SG10202000552YA (en) 2020-03-30

Family

ID=41698391

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201504623VA SG10201504623VA (en) 2008-09-24 2009-09-23 Peptides and compositions for prevention of cell adhesion and methods of using same
SG10202000552YA SG10202000552YA (en) 2008-09-24 2009-09-23 Peptides and compositions for prevention of cell adhesion and methods of using same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201504623VA SG10201504623VA (en) 2008-09-24 2009-09-23 Peptides and compositions for prevention of cell adhesion and methods of using same

Country Status (12)

Country Link
US (3) US9029318B2 (de)
EP (3) EP2344521B1 (de)
JP (2) JP5676451B2 (de)
KR (2) KR101788284B1 (de)
CN (2) CN104892728A (de)
AU (1) AU2009295575B2 (de)
CA (1) CA2737682C (de)
ES (2) ES2690348T3 (de)
HK (1) HK1213903A1 (de)
IL (1) IL211930A (de)
SG (2) SG10201504623VA (de)
WO (1) WO2010035107A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2684150C (en) 2007-05-14 2016-10-04 Research Foundation Of State University Of New York Decenoic acid dispersion inducers in the treatment of biofilms
EP2344521B1 (de) 2008-09-24 2019-08-21 Tel HaShomer Medical Research Infrastructure and Services Ltd. Peptide und zusammensetzungen zur prävention von zellenadhäsion und verfahren zu deren verwendung
US11174299B2 (en) 2008-12-29 2021-11-16 Dispersebio Ltd. Peptides and compositions for prevention of cell adhesion and methods of using same
EP2376528B1 (de) 2008-12-29 2014-11-26 Tel Hashomer Medical Research, Infrastructure And Services Ltd. Peptide und zusammensetzungen zur prävention von zellenadhäsion und verfahren zu deren verwendung
AU2012264385B2 (en) * 2011-05-31 2018-06-28 Hutchison Biofilm Medical Solutions Limited Dispersion and detachment of cell aggregates
CN104053668B (zh) 2011-11-30 2020-09-11 新加坡科技研究局 用于生物学检测的gm1神经节苷脂与膜联蛋白v的微粒多肽比例
SG10201803535RA (en) * 2013-10-31 2018-05-30 Hutchison Biofilm Medical Solutions Ltd Use of peptides in antibiotic resistance
JP6443235B2 (ja) * 2015-06-15 2018-12-26 三菱ケミカル株式会社 細胞外多糖類の検出を使用した汚泥の脱水方法
KR101819190B1 (ko) * 2015-10-14 2018-01-16 주식회사 큐얼스 미세조류 파괴용 조성물
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN113490536B (zh) * 2018-11-01 2023-12-29 百福灵科技股份有限公司 持久的生物结垢保护
EP3699185A1 (de) * 2019-02-20 2020-08-26 Université de Rennes 1 Peptide zur verhinderung der biofilmbildung
KR102277536B1 (ko) 2019-04-25 2021-07-15 동국대학교 산학협력단 생물오손 방지를 위한 체내 삽입형 의료기기 및 체내 삽입형 의료기기의 표면에 생물오손 방지막의 형성방법
KR102520633B1 (ko) 2021-02-17 2023-04-11 동의대학교 산학협력단 흡수성이 향상된 치과용 멤브레인 필터 및 그 제조방법

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4286988A (en) 1980-06-30 1981-09-01 The United States Of America As Represented By The Secretary Of The Navy Copper base antifouling paints with pH control
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US4678512A (en) 1982-02-12 1987-07-07 Grams Ralph R Marine coating compositions and method
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
GB8511144D0 (en) 1985-05-02 1985-06-12 Int Paint Plc Marine anti-fouling paint
JPH07764Y2 (ja) 1987-05-19 1995-01-11 日産自動車株式会社 自動変速機のロツクアツプ制御装置
US4865909A (en) 1987-10-21 1989-09-12 W. L. Gore & Associates, Inc. Microporous anti-fouling marine coating
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5143545A (en) 1991-09-20 1992-09-01 The United States Of America As Represented By The Secretary Of The Navy Antifouling marine coatings
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
AU1432595A (en) 1993-12-09 1995-06-27 Research Foundation Of The State University Of New York, The Aquatic antifouling compositions and methods
AUPQ002399A0 (en) * 1999-04-28 1999-05-20 Australian National University, The Model membrane systems
US7834146B2 (en) * 2000-05-08 2010-11-16 Monsanto Technology Llc Recombinant polypeptides associated with plants
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US7189351B2 (en) * 2001-10-25 2007-03-13 Spherix Incorporated D-tagatose as an anti-biofilm agent
WO2003050708A1 (en) 2001-12-07 2003-06-19 Vitesse Semiconductor Company A method and system for transporting information via the xgmii or fiber channel standard
GB0200689D0 (en) * 2002-01-10 2002-02-27 Univ Newcastle Fusion proteins
CN1162541C (zh) * 2002-09-03 2004-08-18 中山大学 一种海葵细胞毒素基因、其编码的蛋白及应用
EP2256198A1 (de) * 2004-06-14 2010-12-01 Galapagos N.V. Identifizierungsverfahren und Verbindungen für die Behandlung degenerativer und entzündlicher Erkrankungen
EP2138195A3 (de) 2004-06-16 2010-07-21 Affinergy Inc. Grenzflächenbiomaterialien zur Förderung der Anhaftung von Zielanalyten
US20090156471A1 (en) 2004-07-15 2009-06-18 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
GB0502046D0 (en) * 2005-02-01 2005-03-09 Sinclair Pharmaceuticals Ltd Method
EP1919494A4 (de) 2005-07-22 2011-11-09 Univ Colorado Regents Nichttoxischer biofolien-hemmer
US8048443B2 (en) * 2005-12-16 2011-11-01 Cerapedics, Inc. Pliable medical device and method of use
US20070293435A1 (en) 2006-06-16 2007-12-20 Naomi Balaban Identification and Use of Non-Peptide Analogs of RNAIII-Inhibiting Peptide for the Treatment of Staphylococcal Infections
BRPI0809248A2 (pt) * 2007-03-22 2014-09-23 Dsm Ip Assests Bv Lisil oxidase
US20080241281A1 (en) 2007-03-29 2008-10-02 Texas Tech University System Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development
KR20140068239A (ko) 2007-09-20 2014-06-05 텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드． 세포 유착을 방지하기 위한 수생 기원의 조성물 및 그것의 사용 방법
US8551555B2 (en) * 2007-12-26 2013-10-08 Intel Corporation Biocompatible coatings for medical devices
EP2344521B1 (de) * 2008-09-24 2019-08-21 Tel HaShomer Medical Research Infrastructure and Services Ltd. Peptide und zusammensetzungen zur prävention von zellenadhäsion und verfahren zu deren verwendung
EP2376528B1 (de) 2008-12-29 2014-11-26 Tel Hashomer Medical Research, Infrastructure And Services Ltd. Peptide und zusammensetzungen zur prävention von zellenadhäsion und verfahren zu deren verwendung
JP6208358B2 (ja) 2014-07-09 2017-10-04 ジヤトコ株式会社 ロックアップクラッチの制御装置

Also Published As

Publication number Publication date
KR20110074868A (ko) 2011-07-04
US9029318B2 (en) 2015-05-12
EP2789626B1 (de) 2018-07-18
KR101788284B1 (ko) 2017-10-19
WO2010035107A3 (en) 2010-05-20
CN104892728A (zh) 2015-09-09
US20110280920A1 (en) 2011-11-17
US11001612B2 (en) 2021-05-11
JP2012503597A (ja) 2012-02-09
SG10201504623VA (en) 2015-07-30
CA2737682C (en) 2016-01-12
JP5750703B2 (ja) 2015-07-22
IL211930A (en) 2017-11-30
CN102171239B (zh) 2018-11-13
US20180016311A1 (en) 2018-01-18
WO2010035107A2 (en) 2010-04-01
EP2789626A3 (de) 2015-06-17
EP2344521B1 (de) 2019-08-21
EP2344521A2 (de) 2011-07-20
EP2789626A2 (de) 2014-10-15
AU2009295575B2 (en) 2015-11-05
IL211930A0 (en) 2011-06-30
US20150315253A1 (en) 2015-11-05
CA2737682A1 (en) 2010-04-01
KR101594202B1 (ko) 2016-02-15
WO2010035107A9 (en) 2010-07-15
CN102171239A (zh) 2011-08-31
AU2009295575A1 (en) 2010-04-01
KR20150134441A (ko) 2015-12-01
US9777050B2 (en) 2017-10-03
ES2753900T3 (es) 2020-04-14
EP3670524A1 (de) 2020-06-24
HK1213903A1 (zh) 2016-07-15
JP2015037545A (ja) 2015-02-26
JP5676451B2 (ja) 2015-02-25
ES2690348T3 (es) 2018-11-20

Similar Documents

Publication Publication Date Title
HK1213903A1 (zh) 用於防止細胞粘附的肽和組合物及其使用方法
HK1161607A1 (en) Peptides and compositions for prevention of cell adhesion and methods of using same
IL217389A0 (en) Methods and compositions for the recombinant biosynthesis of n-alkanes
IL209136A0 (en) Compositions of peptides and processes of preparation thereof
EP2373679A4 (de) Mini-hepcidinpeptide und verfahren zu ihrer verwendung
EP2334185A4 (de) Zusammensetzungen und verfahren zur verwendung von (r)-pramipexol
HK1144823A1 (en) Compositions and methods of using proislet peptides and analogs thereof
GB201006373D0 (en) Sealing compositions and methods
IL224959A (en) Methods and preparations for producing bax-free cell lines
EP2442829A4 (de) Strukturierte viralpeptidzusammensetzungen und verwendungsverfahren dafür
HK1153360A1 (en) Sweetener compositions and methods of making them
HK1144319A1 (en) Compositions and methods of detecting tiabs
SG10201701670SA (en) Compositions of aquatic origin for prevention of cell adhesion and methods of using same
EP2356462A4 (de) Anti-cxcr1-zusammensetzungen und verfahren
IL208445A0 (en) Compositions and methods for immunotherapy
EP2346521A4 (de) Peptide und verwendungsverfahren dafür
EP2274002A4 (de) Leucinreiche peptid-zusammensetzungen und gewinnungsverfahren
HK1140019A1 (en) Compositions and methods of detection
IL207827A0 (en) Apoaequorin-containing compositions and methods of using same
HK1151242A1 (en) Mntf peptide compositions and methods of use mntf
IL204645A0 (en) Compositions of aquatic origin for prevention of cell adhesion and methods of using same
PL385727A1 (pl) Kompozycja przeznaczona na płyty uszczelniające i sposób przygotowania kompozycji na płyty uszczelniające
GB0820492D0 (en) Cell compositions and uses thereof
GB0803464D0 (en) Methods and compositions
GB0811152D0 (en) Methods and compositions